Global Cardiovascular Partnering 2014-2019: Deal trends, players and financials

Global Cardiovascular Partnering 2014 to 2019 provides the full collection of Cardiovascular disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.